Schroder Investment Management Group Raises Stock Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Schroder Investment Management Group lifted its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 10.8% during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 5,111,062 shares of the pharmacy operator's stock after buying an additional 498,674 shares during the quarter. Schroder Investment Management Group owned approximately 0.59% of Walgreens Boots Alliance worth $47,686,000 at the end of the most recent quarter.

Other hedge funds also recently bought and sold shares of the company. Intech Investment Management LLC purchased a new position in Walgreens Boots Alliance in the 3rd quarter worth approximately $109,000. The Manufacturers Life Insurance Company lifted its holdings in shares of Walgreens Boots Alliance by 31.0% in the third quarter. The Manufacturers Life Insurance Company now owns 572,192 shares of the pharmacy operator's stock worth $5,127,000 after buying an additional 135,343 shares in the last quarter. D.A. Davidson & CO. boosted its position in shares of Walgreens Boots Alliance by 2.6% during the third quarter. D.A. Davidson & CO. now owns 127,776 shares of the pharmacy operator's stock worth $1,145,000 after acquiring an additional 3,203 shares during the last quarter. FMR LLC increased its holdings in shares of Walgreens Boots Alliance by 2.5% in the third quarter. FMR LLC now owns 3,258,919 shares of the pharmacy operator's stock worth $29,200,000 after purchasing an additional 80,525 shares during the last quarter. Finally, Bridgewater Associates LP purchased a new stake in shares of Walgreens Boots Alliance in the third quarter worth about $160,000. Institutional investors own 58.59% of the company's stock.

Remove Ads

Analyst Upgrades and Downgrades

A number of analysts have issued reports on WBA shares. Truist Financial reduced their price objective on Walgreens Boots Alliance from $13.00 to $12.00 and set a "hold" rating on the stock in a research note on Friday, January 31st. Deutsche Bank Aktiengesellschaft cut Walgreens Boots Alliance from a "hold" rating to a "sell" rating and reduced their price objective for the stock from $11.00 to $9.00 in a research note on Friday, February 28th. Bank of America lifted their target price on Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an "underperform" rating in a report on Monday, January 13th. StockNews.com initiated coverage on shares of Walgreens Boots Alliance in a research note on Wednesday, March 26th. They issued a "hold" rating on the stock. Finally, Evercore ISI lifted their price target on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an "in-line" rating in a research note on Monday, January 13th. Four research analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have issued a buy rating to the company's stock. According to data from MarketBeat.com, the company has an average rating of "Hold" and a consensus target price of $10.59.

Walgreens Boots Alliance Stock Up 0.2 %

NASDAQ WBA traded up $0.02 during trading on Wednesday, reaching $11.18. 9,233,294 shares of the company's stock traded hands, compared to its average volume of 20,797,126. Walgreens Boots Alliance, Inc. has a 12-month low of $8.08 and a 12-month high of $19.48. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.64 and a quick ratio of 0.30. The firm has a market cap of $9.66 billion, a price-to-earnings ratio of -1.09, a price-to-earnings-growth ratio of 1.31 and a beta of 0.62. The company's 50 day simple moving average is $10.79 and its two-hundred day simple moving average is $9.95.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last issued its quarterly earnings data on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share for the quarter, beating analysts' consensus estimates of $0.38 by $0.13. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The company had revenue of $39.50 billion for the quarter, compared to the consensus estimate of $37.40 billion. During the same quarter last year, the company earned $0.66 earnings per share. The firm's revenue for the quarter was up 7.6% compared to the same quarter last year. As a group, sell-side analysts forecast that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current fiscal year.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.